98%
921
2 minutes
20
Background & Aims: The visualization of the whole colonic mucosa with complete colonoscopy including cecal intubation has been accepted as a quality parameter for screening colonoscopy. However, there is little evidence regarding the cecal intubation rate (CIR) and its association with long-term patient outcome.
Methods: We did a linkage of individuals that participated in an Austrian Colonoscopy Quality Assurance Program to the Austrian death registry to obtain information on deaths of post-colonoscopy colorectal cancer (PCCRC). We performed logistic regression and time-to-event analyses to estimate the association the CIR with the probability to detect adenomas or proximal serrated polyps and the hazards for PCCRC death.
Results: A total of 349,782 screening participants between January 2012 and December 2022 were included. With every 1 percentage point increase in the CIR, the probability to detect an adenoma increased by 1 percentage point (odds ratio, 1.01; 95% confidence interval [CI], 1.0-1.01; P < .001) and increased by 3 percentage points to detect a proximal serrated polyp (odds ratio, 1.03; 95% CI, 1.01-1.04; P < .001). There was a significantly lower risk for PCCRC death when endoscopists had a CIR of 95% to 100% (hazard ratio, 0.44; 95% CI, 0.33-0.59; P < .001), compared with endoscopists with a CIR <90% or 90% to 95%.
Conclusions: The endoscopist's CIR is strongly associated with their ability to detect adenomas and proximal serrated polyps. A CIR of 95% to 100% was associated with the lowest hazards for PCCRC death. Based on this data, a CIR above 95% is the desirable target.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cgh.2025.01.035 | DOI Listing |
Inflamm Bowel Dis
September 2025
Department of internal medicine, School of Medicine, Faculty of Medicine, Tel-Aviv University, Tel‑Aviv, Israel.
Objectives: The real-world efficacy of computer-aided detection (CADe) in improving surveillance colonoscopy performance for patients with inflammatory bowel disease (IBD) has not been established.
Methods: A retrospective, single-center study of surveillance colonoscopies in patients with IBD. Only colonoscopies indicated for surveillance, with adequate preparation and documented cecal intubation, were included.
BMC Gastroenterol
August 2025
Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background: Colonoscopy is important for diagnosis, assessment and dysplasia screening in inflammatory bowel disease (IBD). A good bowel preparation is required for complete and adequate assessment.
Trial Design: Randomised, assessor blinded parallel arm trial with 1:1 allocation.
Acta Anaesthesiol Scand
October 2025
Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
Aim: This scoping review aims to map evidence on sex differences in colonoscopy sedation use and their impact on colonoscopy quality indicators (CQIs).
Methods: The review will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The search will be conducted using MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials.
Medicine (Baltimore)
August 2025
Department of Emergency, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
Colonoscopy provides limited protection against interval colorectal cancer. This study aims to investigate the application value of transparent-cap-assisted colonoscopy (CAC) regarding cecal intubation time and polyp detection rate. This prospective randomized controlled trial recruited 480 patients in our hospitals.
View Article and Find Full Text PDFCurr Gastroenterol Rep
August 2025
University of Texas Health San Antonio, San Antonio, USA.
Purpose Of Review: This review summarizes current landscape of colonoscopy quality metrics, with an emphasis on priority intraprocedural indicators. We aim to clarify the rationale, evidence, and practical implementation of both traditional and recently introduced metrics-highlighting which measures are most relevant for improving patient outcomes in 2025.
Recent Findings: The 2024 ACG/ASGE guidelines reaffirmed the core quality indicators of adenoma detection rate (ADR), cecal intubation rate (CIR), bowel preparation adequacy, and guideline-based surveillance interval assignment.